Free Trial

Adagio Medical (ADGM) Competitors

Adagio Medical logo
$0.72 -0.02 (-3.32%)
Closing price 04:00 PM Eastern
Extended Trading
$0.72 0.00 (0.00%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADGM vs. GPMT, KVAC, SWSS, CRT, and VHC

Should you buy Adagio Medical stock or one of its competitors? MarketBeat compares Adagio Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Adagio Medical include Granite Point Mortgage Trust (GPMT), Keen Vision Acquisition (KVAC), Clean Energy Special Situations (SWSS), Cross Timbers Royalty Trust (CRT), and Virnetx (VHC). These companies are all part of the "trading" industry.

How does Adagio Medical compare to Granite Point Mortgage Trust?

Granite Point Mortgage Trust (NYSE:GPMT) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Granite Point Mortgage Trust presently has a consensus target price of $2.50, suggesting a potential upside of 62.87%. Adagio Medical has a consensus target price of $3.50, suggesting a potential upside of 382.76%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts clearly believe Adagio Medical is more favorable than Granite Point Mortgage Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Granite Point Mortgage Trust
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Adagio Medical has lower revenue, but higher earnings than Granite Point Mortgage Trust. Granite Point Mortgage Trust is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Granite Point Mortgage Trust$131.73M0.56-$41.15M-$1.07N/A
Adagio Medical$600K26.84-$25.08M-$1.53N/A

In the previous week, Adagio Medical had 1 more articles in the media than Granite Point Mortgage Trust. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Granite Point Mortgage Trust. Adagio Medical's average media sentiment score of 0.75 beat Granite Point Mortgage Trust's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Granite Point Mortgage Trust Neutral
Adagio Medical Positive

51.6% of Granite Point Mortgage Trust shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 3.1% of Granite Point Mortgage Trust shares are held by company insiders. Comparatively, 5.2% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Granite Point Mortgage Trust has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, meaning that its stock price is 119% less volatile than the broader market.

Adagio Medical has a net margin of 0.00% compared to Granite Point Mortgage Trust's net margin of -29.82%. Granite Point Mortgage Trust's return on equity of -11.31% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Granite Point Mortgage Trust-29.82% -11.31% -3.65%
Adagio Medical N/A -382.50%-64.98%

Summary

Adagio Medical beats Granite Point Mortgage Trust on 10 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Keen Vision Acquisition?

Adagio Medical (NASDAQ:ADGM) and Keen Vision Acquisition (NASDAQ:KVAC) are both small-cap trading companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Keen Vision Acquisition has lower revenue, but higher earnings than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K26.84-$25.08M-$1.53N/A
Keen Vision AcquisitionN/AN/AN/AN/AN/A

Adagio Medical has a beta of -0.19, suggesting that its share price is 119% less volatile than the broader market. Comparatively, Keen Vision Acquisition has a beta of -0.03, suggesting that its share price is 103% less volatile than the broader market.

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 51.7% of Keen Vision Acquisition shares are held by institutional investors. 5.2% of Adagio Medical shares are held by company insiders. Comparatively, 47.8% of Keen Vision Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Adagio Medical presently has a consensus price target of $3.50, indicating a potential upside of 382.76%. Given Adagio Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Adagio Medical is more favorable than Keen Vision Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Keen Vision Acquisition
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Adagio Medical had 1 more articles in the media than Keen Vision Acquisition. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Keen Vision Acquisition. Adagio Medical's average media sentiment score of 0.75 beat Keen Vision Acquisition's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the media.

Company Overall Sentiment
Adagio Medical Positive
Keen Vision Acquisition Neutral

Keen Vision Acquisition's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A -382.50% -64.98%
Keen Vision Acquisition N/A N/A N/A

Summary

Adagio Medical beats Keen Vision Acquisition on 6 of the 11 factors compared between the two stocks.

How does Adagio Medical compare to Clean Energy Special Situations?

Adagio Medical (NASDAQ:ADGM) and Clean Energy Special Situations (NASDAQ:SWSS) are both small-cap trading companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Clean Energy Special Situations has lower revenue, but higher earnings than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K26.84-$25.08M-$1.53N/A
Clean Energy Special SituationsN/AN/A$840KN/AN/A

In the previous week, Adagio Medical had 1 more articles in the media than Clean Energy Special Situations. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Clean Energy Special Situations. Adagio Medical's average media sentiment score of 0.75 beat Clean Energy Special Situations' score of 0.00 indicating that Adagio Medical is being referred to more favorably in the media.

Company Overall Sentiment
Adagio Medical Positive
Clean Energy Special Situations Neutral

Clean Energy Special Situations' return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A -382.50% -64.98%
Clean Energy Special Situations N/A N/A N/A

Adagio Medical has a beta of -0.19, meaning that its stock price is 119% less volatile than the broader market. Comparatively, Clean Energy Special Situations has a beta of 0.02, meaning that its stock price is 98% less volatile than the broader market.

Adagio Medical presently has a consensus price target of $3.50, suggesting a potential upside of 382.76%. Given Adagio Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Adagio Medical is more favorable than Clean Energy Special Situations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Clean Energy Special Situations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 23.5% of Clean Energy Special Situations shares are owned by institutional investors. 5.2% of Adagio Medical shares are owned by company insiders. Comparatively, 86.0% of Clean Energy Special Situations shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Adagio Medical beats Clean Energy Special Situations on 7 of the 12 factors compared between the two stocks.

How does Adagio Medical compare to Cross Timbers Royalty Trust?

Cross Timbers Royalty Trust (NYSE:CRT) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Adagio Medical has a consensus price target of $3.50, suggesting a potential upside of 382.76%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts clearly believe Adagio Medical is more favorable than Cross Timbers Royalty Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Timbers Royalty Trust
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Cross Timbers Royalty Trust has a net margin of 71.40% compared to Adagio Medical's net margin of 0.00%. Cross Timbers Royalty Trust's return on equity of 145.81% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Timbers Royalty Trust71.40% 145.81% 83.88%
Adagio Medical N/A -382.50%-64.98%

Cross Timbers Royalty Trust has a beta of -0.04, indicating that its share price is 104% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, indicating that its share price is 119% less volatile than the broader market.

9.7% of Cross Timbers Royalty Trust shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 9.4% of Cross Timbers Royalty Trust shares are held by insiders. Comparatively, 5.2% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cross Timbers Royalty Trust has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Cross Timbers Royalty Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Timbers Royalty Trust$5.79M11.10$6.15M$0.5419.84
Adagio Medical$600K26.84-$25.08M-$1.53N/A

In the previous week, Adagio Medical had 1 more articles in the media than Cross Timbers Royalty Trust. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Cross Timbers Royalty Trust. Cross Timbers Royalty Trust's average media sentiment score of 1.95 beat Adagio Medical's score of 0.75 indicating that Cross Timbers Royalty Trust is being referred to more favorably in the media.

Company Overall Sentiment
Cross Timbers Royalty Trust Very Positive
Adagio Medical Positive

Summary

Cross Timbers Royalty Trust beats Adagio Medical on 10 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Virnetx?

Virnetx (NASDAQ:VHC) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

10.4% of Virnetx shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 15.7% of Virnetx shares are owned by company insiders. Comparatively, 5.2% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Virnetx has a beta of 2.24, meaning that its share price is 124% more volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, meaning that its share price is 119% less volatile than the broader market.

In the previous week, Adagio Medical had 1 more articles in the media than Virnetx. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Virnetx. Adagio Medical's average media sentiment score of 0.75 beat Virnetx's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Virnetx Neutral
Adagio Medical Positive

Adagio Medical has a consensus price target of $3.50, suggesting a potential upside of 382.76%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Virnetx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Virnetx
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Virnetx has higher earnings, but lower revenue than Adagio Medical. Virnetx is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Virnetx$160K401.48-$18.23M-$5.16N/A
Adagio Medical$600K26.84-$25.08M-$1.53N/A

Virnetx's return on equity of -72.84% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
VirnetxN/A -72.84% -54.96%
Adagio Medical N/A -382.50%-64.98%

Summary

Adagio Medical beats Virnetx on 9 of the 15 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$16.66M$7.39B$6.48B$12.46B
Dividend YieldN/A1.19%2.67%5.34%
P/E Ratio-0.4745.8723.9323.64
Price / Sales26.8474.36517.31112.52
Price / CashN/A24.8842.3557.17
Price / Book1.237.049.736.37
Net Income-$25.08M$159.22M$3.56B$337.36M
7 Day Performance0.14%-2.42%-3.19%-3.07%
1 Month Performance-26.02%3.38%-0.11%0.37%
1 Year Performance-35.27%0.90%25.29%27.87%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
3.0161 of 5 stars
$0.73
-3.3%
$3.50
+382.8%
-37.0%$16.66M$600KN/A87
GPMT
Granite Point Mortgage Trust
3.4341 of 5 stars
$1.44
+2.9%
$2.50
+73.6%
-40.1%$69.01M$131.73MN/A30
KVAC
Keen Vision Acquisition
N/A$12.32
+0.2%
N/A+8.7%$67.91MN/AN/AN/A
SWSS
Clean Energy Special Situations
N/A$10.70
flat
N/AN/A$67.31MN/AN/A3
CRT
Cross Timbers Royalty Trust
2.5728 of 5 stars
$10.90
-0.4%
N/A+10.6%$65.40M$5.79M20.19N/A

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 6/5/2026 by MarketBeat.com Staff.
From Our Partners